LABCORP HOLDINGS INC. (LH) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 2.12B USD | Liabilities, Current |
| Cash and equivalents | 141.80M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 2.34B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 562.20M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $2.12B | $141.80M | (m) | $2.34B | $562.20M | (m) |
| 2026-03-31 | (m) | $2.64B | $981.10M | (m) | $2.29B | $497.70M | (m) |
| 2025-12-31 | (m) | $2.82B | $532.30M | (m) | $2.10B | $534.70M | (m) |
| 2025-09-30 | (m) | $2.63B | $598.10M | (m) | $2.11B | $521.50M | (m) |
| 2025-06-30 | (m) | $2.72B | $647.30M | (m) | $2.12B | $508.10M | (m) |
| 2025-03-31 | (m) | $2.06B | $369.40M | (m) | $2.12B | $488.30M | (m) |
| 2024-12-31 | (m) | $3.33B | $1.52B | (m) | $1.94B | $493.20M | (m) |
| 2024-09-30 | (m) | $3.41B | $1.52B | (m) | $2.06B | $483.10M | (m) |
| 2024-06-30 | (m) | $4.06B | $265.10M | (m) | $2.09B | $441.80M | (m) |
| 2024-03-31 | (m) | $3.94B | $99.30M | (m) | $2.08B | $475.00M | (m) |
| 2023-12-31 | (m) | $3.23B | $536.80M | (m) | $1.91B | $474.60M | (m) |
| 2023-09-30 | (m) | $2.90B | $727.90M | (m) | $1.96B | $461.10M | (m) |
| 2023-06-30 | (m) | $2.18B | $1.93B | (m) | $1.90B | $487.80M | (m) |
| 2023-03-31 | (m) | $2.89B | $393.90M | (m) | $2.34B | $481.40M | (m) |
| 2022-12-31 | (m) | $3.08B | $430.00M | (m) | $2.22B | $470.60M | (m) |
| 2022-09-30 | (m) | $2.52B | $409.90M | (m) | $2.16B | $467.70M | (m) |
| 2022-06-30 | (m) | $2.64B | $1.07B | (m) | $2.22B | $436.30M | (m) |
| 2022-03-31 | (m) | $2.64B | $1.23B | (m) | $2.24B | $440.70M | (m) |
| 2021-12-31 | (m) | $2.78B | $1.47B | (m) | $2.26B | $401.40M | (m) |
| 2021-09-30 | (m) | $2.89B | $2.04B | (m) | $2.34B | $410.70M | (m) |
| 2021-06-30 | (m) | $2.67B | $1.96B | (m) | $2.21B | $421.30M | (m) |
| 2021-03-31 | (m) | $3.37B | $1.89B | (m) | $2.32B | $427.50M | (m) |
| 2020-12-31 | (m) | $3.08B | $1.32B | (m) | $2.48B | $423.20M | (m) |
| 2020-09-30 | (m) | $3.01B | $667.20M | (m) | $2.10B | $392.50M | (m) |
| 2020-06-30 | (m) | $3.03B | $557.00M | (m) | $1.66B | $342.30M | (m) |
| 2020-03-31 | (m) | $2.46B | $323.60M | (m) | $1.48B | $254.00M | (m) |
| 2019-12-31 | (m) | $2.66B | $337.50M | (m) | $1.54B | $244.70M | (m) |
| 2019-09-30 | (m) | $2.55B | $361.10M | (m) | $1.62B | $234.90M | (m) |
| 2019-06-30 | (m) | $2.50B | $265.40M | (m) | $1.58B | $219.70M | (m) |
| 2019-03-31 | (m) | $2.53B | $348.80M | (m) | $1.56B | $233.70M | (m) |
| 2018-12-31 | (m) | $1.88B | $426.80M | (m) | $1.47B | $237.30M | (m) |
| 2018-09-30 | (m) | $2.11B | $892.60M | (m) | $1.54B | $233.00M | (m) |
| 2018-06-30 | (m) | $2.12B | $221.40M | (m) | $1.52B | $230.70M | (m) |
| 2018-03-31 | (m) | $2.10B | $361.80M | (m) | $1.61B | $226.20M | (m) |
| 2017-12-31 | (m) | $2.05B | $316.70M | (m) | $1.48B | $227.60M | (m) |
| 2017-09-30 | (m) | $1.54B | $409.30M | (m) | $1.56B | $217.20M | (m) |
| 2017-06-30 | (m) | $1.81B | $299.90M | (m) | $1.38B | $209.90M | (m) |
| 2017-03-31 | (m) | $1.75B | $365.50M | (m) | $1.36B | $199.80M | (m) |
| 2016-12-31 | (m) | $1.83B | $433.60M | (m) | $1.33B | $205.20M | (m) |
| 2016-09-30 | (m) | $1.91B | $567.60M | (m) | $1.35B | $198.80M | (m) |
| 2016-06-30 | (m) | $1.27B | $639.60M | (m) | $1.31B | $189.60M | (m) |
| 2016-03-31 | (m) | $1.64B | $696.30M | (m) | $1.33B | $188.20M | (m) |
| 2015-12-31 | (m) | $1.70B | $716.40M | (m) | $1.22B | $191.00M | (m) |
| 2015-09-30 | (m) | $1.84B | $713.00M | (m) | $1.24B | $181.60M | (m) |
| 2015-06-30 | (m) | $1.82B | $619.00M | (m) | $1.20B | $182.00M | (m) |
| 2015-03-31 | (m) | $1.41B | $446.40M | (m) | $1.19B | $186.50M | (m) |
| 2014-12-31 | (m) | $976.30M | $580.00M | (m) | $815.70M | $139.50M | (m) |
| 2014-09-30 | (m) | $749.00M | $575.70M | (m) | $841.60M | $138.80M | (m) |
| 2014-06-30 | (m) | $740.80M | $479.50M | (m) | $832.60M | $134.50M | (m) |
| 2014-03-31 | (m) | $753.60M | $338.90M | (m) | $822.00M | $134.80M | (m) |
| 2013-12-31 | (m) | $735.70M | $404.00M | (m) | $784.70M | $136.50M | (m) |
| 2013-09-30 | (m) | $680.60M | $174.10M | (m) | $813.20M | $126.50M | (m) |
| 2013-06-30 | (m) | $655.10M | $111.30M | (m) | $815.70M | $126.40M | (m) |
| 2013-03-31 | (m) | $740.50M | $185.80M | (m) | $793.80M | $124.00M | (m) |
| 2012-12-31 | (m) | $1.03B | $466.80M | (m) | $718.50M | $121.00M | (m) |
| 2012-09-30 | (m) | $1.12B | $466.00M | (m) | $768.90M | $118.90M | (m) |
| 2012-06-30 | (m) | $718.50M | $124.40M | (m) | $735.80M | $114.00M | (m) |
| 2012-03-31 | (m) | $769.20M | $129.90M | (m) | $751.70M | $107.00M | (m) |
| 2011-12-31 | (m) | $797.40M | $159.30M | (m) | $699.80M | $110.80M | (m) |
| 2011-09-30 | (m) | $982.20M | $85.80M | (m) | $718.70M | $103.80M | (m) |
| 2011-06-30 | (m) | $1.03B | $118.90M | (m) | $714.80M | $106.80M | (m) |
| 2011-03-31 | (m) | $1.20B | $195.40M | (m) | $717.30M | $98.00M | (m) |
| 2010-12-31 | (m) | $1.12B | $230.70M | (m) | $655.60M | $103.40M | (m) |
| 2010-09-30 | (m) | $951.30M | $96.90M | (m) | $631.00M | $88.20M | (m) |
| 2010-06-30 | (m) | $895.60M | $103.80M | (m) | $617.60M | $86.30M | (m) |
| 2010-03-31 | (m) | $886.40M | $172.20M | (m) | $614.30M | $82.50M | (m) |
| 2009-12-31 | (m) | $1.02B | $148.50M | (m) | $574.20M | $90.00M | (m) |
| 2009-09-30 | (m) | $602.60M | $126.80M | (m) | $636.90M | $81.60M | (m) |
| 2009-06-30 | (m) | $553.50M | $226.60M | (m) | $655.30M | $71.20M | (m) |
| 2009-03-31 | (m) | (m) | $373.20M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $546.90M | $219.70M | (m) | $631.60M | $91.00M | (m) |
| 2008-09-30 | (m) | (m) | $49.40M | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | $155.30M | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | $56.40M | (m) | (m) | (m) | (m) |
| 2006-12-31 | (m) | (m) | $51.50M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |